Stock Information
Novavax Inc (NVAX)
Ticker Symbol: NVAX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,525.08 mil
Piotroski score: 6
PE Ratio: 3.5479
EPS (TTM): 2.3677
Revenue (TTM): $5.98 M
Dividend Yield: N/A%
ROE: 283.08%
Latest News
-
Novavax to Participate in BofA Securities 2026 Health Care Conference
Thu, May 7, 2026 4:03 PM
-
Earnings Scheduled For May 6, 2026
Wed, May 6, 2026 5:03 PM
-
TD Cowen Maintains Hold on Novavax, Raises Price Target to $9
Wed, May 6, 2026 3:42 PM
-
Why Novavax Stock Is Trading Higher On Wednesday?
Wed, May 6, 2026 3:07 PM
-
Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript
Wed, May 6, 2026 2:21 PM
-
Transcript : Novavax, Inc., Q1 2026 Earnings Call, May 06, 2026
Wed, May 6, 2026 2:05 PM
-
Novavax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Wed, May 6, 2026 11:37 AM
-
Novavax Q1 2026 Earnings Call Transcript
Wed, May 6, 2026 9:54 AM
-
Novavax : Q1 Reports & Financials (nvax q1 2026 earnings presentation)
Wed, May 6, 2026 9:20 AM
-
Novavax beats first-quarter revenue estimates on strength in vaccine deals
Wed, May 6, 2026 8:22 AM
Key Financials
Financial data not available